Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Hengsheng Pharmaceutical is a comprehensive pharmaceutical enterprise based in China, specializing in the research, development, production, and sale of chemical drugs and active pharmaceutical ingredients (APIs). The company operates large-scale manufacturing facilities that produce a wide range of dosage forms, including tablets, capsules, granules, and small-volume injections. Its product portfolio primarily focuses on therapeutic areas such as gastroenterology, cardiovascular health, and anti-infectives, with notable products including proton pump inhibitors and antihypertensive agents. Hunan Hengsheng Pharmaceutical is recognized for its integrated supply chain, maintaining both API production and finished drug formulation capabilities to ensure quality and cost-efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Hengsheng Pharmaceutical.